EBS vs ROST · rev $1.04B vs P/E 21, rev $21.13B
Emergent Biosolutions Inc (EBS) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
EBS currently screens at market cap $416.4M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the EBS and ROST stock pages for the full models.
Not investment advice.